
    
      Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICROâ„¢ Catheter to
      demonstrate the safety and effectiveness when compared to an historical control performance
      goal.

      the trial has two arms: main arm and second arm (variable flow). The main arm will enroll 185
      subjects and second arm will enroll 92 subjects.
    
  